Cargando…
Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer
BACKGROUND: Follistatin-like 1 (FSTL1) plays a central role in the progression of tumor and tumor immunity. However, the effect of FSTL1 on the prognosis and immune infiltration of gastric cancer (GC) remains to be elucidated. METHODS: The expression of FSTL1 data was analyzed in Oncomine and TIMER...
Autores principales: | Li, Li, Huang, Shanshan, Yao, Yangyang, Chen, Jun, Li, Junhe, Xiang, Xiaojun, Deng, Jun, Xiong, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724795/ https://www.ncbi.nlm.nih.gov/pubmed/33292276 http://dx.doi.org/10.1186/s12957-020-02070-9 |
Ejemplares similares
-
The BMP inhibitor follistatin-like 1 (FSTL1) suppresses cervical carcinogenesis
por: Zhao, Chenjing, et al.
Publicado: (2023) -
A role for Follistatin-like protein 1 (FSTL1) in colorectal cancer
por: Voutsadakis, Ioannis A.
Publicado: (2020) -
FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration
por: Liu, Yuan-Jie, et al.
Publicado: (2021) -
Follistatin like-1 (Fstl1) is required for the normal formation of lung airway and vascular smooth muscle at birth
por: Liu, Xue, et al.
Publicado: (2017) -
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma
por: Zhang, Deng-Yong, et al.
Publicado: (2020)